Puma Biotechnology, Inc. (PBYI)

NASDAQ: PBYI · Real-Time Price · USD

Compare

6.48

+0.05 (0.78%)

At close: Jan 30, 2026, 4:00 PM EST

6.51

+0.03 (0.46%)

After-hours: Jan 30, 2026, 6:10 PM EST

Puma Biotechnology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	36.98	30.28	21.59	0	-29.13	-60
Depreciation & Amortization	11.12	11.52	11.52	9.84	11.31	10.03
Asset Writedown & Restructuring Costs	-	-	0.63	7	-	-
Stock-Based Compensation	7.08	8.25	10.25	11.83	32.63	36.58
Provision & Write-off of Bad Debts	-0.76	-0.52	0.88	-	-1	1
Other Operating Activities	0	-	-	0	8.15	-
Change in Accounts Receivable	21.84	16.35	-8.37	-7.82	-5.98	2.35
Change in Inventory	-6.8	-1.64	-2.55	2.58	-3.66	-0.28
Change in Accounts Payable	-1.12	-1.38	0.45	-4.73	-0.9	-7.11
Change in Other Net Operating Assets	-18.27	-16.86	-7.38	-34.52	9.23	18.2
Operating Cash Flow	42.99	38.92	27.01	-15.83	20.65	0.77
Operating Cash Flow Growth	27.32%	44.09%	-	-	2571.41%	-96.55%
Capital Expenditures	-0.12	-0.06	-0.14	-	-	-0.05
Sale (Purchase) of Intangibles	-	-	-12.5	-7	-	-10
Investment in Securities	-11.41	-20.38	-6.49	14.1	-10.88	43.45
Investing Cash Flow	-11.53	-20.44	-19.13	7.1	-10.88	33.4
Long-Term Debt Issued	-	-	-	-	98.5	8.44
Long-Term Debt Repaid	-	-33.33	-	-	-100	-8.44
Net Debt Issued (Repaid)	-44.44	-33.33	-	-	-1.5	-
Issuance of Common Stock	0.13	0.15	-	12.5	-	0.07
Other Financing Activities	-0.89	-0.67	-	-0.28	-30.43	-10
Financing Cash Flow	-45.2	-33.85	-	12.22	-31.93	-9.93
Net Cash Flow	-13.74	-15.37	7.88	3.5	-22.16	24.24
Free Cash Flow	42.87	38.86	26.87	-15.83	20.65	0.73
Free Cash Flow Growth	27.27%	44.64%	-	-	2740.44%	-96.71%
Free Cash Flow Margin	20.22%	16.86%	11.40%	-6.94%	8.16%	0.32%
Free Cash Flow Per Share	0.86	0.79	0.56	-0.35	0.51	0.02
Cash Interest Paid	7.12	10.77	11.63	10.32	10.34	9.7
Cash Income Tax Paid	1.33	1.22	0.74	0.38	0.32	0.21
Levered Free Cash Flow	31.7	29.49	1.79	-1.34	8.08	-17.23
Unlevered Free Cash Flow	36.77	37.28	10.12	5.91	16.08	-8.45
Change in Working Capital	-11.43	-10.61	-17.85	-44.5	-1.31	13.16

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q